参考文献/References:
[1]American Diabetes Association.2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020[J].Diabetes Care,2020,43(Suppl 1):S14-S31.[2]DeFronzo RA,Ferrannini E,Groop L,et al.Type 2 diabetes mellitus[J].Nat Rev Dis Primers,2015,1:15019.[3]Sun H,Saeedi P,Karuranga S,et al.IDF Diabetes Atlas: Global,regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J].Diabetes Res Clin Pract,2022,183:109119.[4]Esteller M.Non-coding RNAs in human disease[J].Nat Rev Genet,2011,12(12):861-874.[5]万淑君,孔祥,吕坤.非编码RNA与糖尿病血管病变的关系[J].上海交通大学学报(医学版),2021,41(5):665-670.[6]陈瑶,秦振英,胡幼芳.miRNA在胰岛素信号传导通路中的作用研究[J].南京医科大学学报(自然科学版),2021,41(3):465-468.[7]Chen Q,Meng X,Liao Q,et al.Versatile interactions and bioinformatics analysis of noncoding RNAs[J].Brief Bioinform,2019,20(5):1781-1794.[8]Chi T,Lin J,Wang M,et al.Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management[J].Front Endocrinol (Lausanne),2021,12:630032.[9]Lee H,Han S,Kwon CS,et al.Biogenesis and regulation of the let-7 miRNAs and their functional implications[J].Protein Cell,2016,7(2):100-113.[10]Saliminejad K,Khorram KH,Soleymani FS,et al.An overview of microRNAs: Biology,functions,therapeutics,and analysis methods[J].J Cell Physiol,2019,234(5):5451-5465.[11]Anastasiadou E,Jacob LS,Slack FJ.Non-coding RNA networks in cancer[J].Nat Rev Cancer,2018,18(1):5-18.[12]Hombach S,Kretz M.Non-coding RNAs: Classification,Biology and Functioning[J].Adv Exp Med Biol,2016,937:3-17.[13]Jonas S,Izaurralde E.Towards a molecular understanding of microRNA-mediated gene silencing[J].Nat Rev Genet,2015,16(7):421-433.[14]Kim CK,Pak TR.miRNA degradation in the mammalian brain[J].Am J Physiol Cell Physiol,2020,319(4):C624-C629.[15]Correia DSM,Gjorgjieva M,Dolicka D,et al.Deciphering miRNAs’ Action through miRNA Editing[J].Int J Mol Sci,2019,20(24):6249.[16]Hill M,Tran N.Global miRNA to miRNA Interactions: Impacts for miR-21[J].Trends Cell Biol,2021,31(1):3-5.[17]Kim M,Zhang X.The Profiling and Role of miRNAs in Diabetes Mellitus[J].J Diabetes Clin Res,2019,1(1):5-23.[18]Xu H,Du X,Xu J,et al.Pancreatic beta cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving beta cell function[J].PLoS Biol,2020,18(2):e3000603.[19]Eliasson L,Esguerra J.MicroRNA Networks in Pancreatic Islet Cells:Normal Function and Type 2 Diabetes[J].Diabetes,2020,69(5):804-812.[20]Eliasson L.The small RNA miR-375 - a pancreatic islet abundant miRNA with multiple roles in endocrine beta cell function[J].Mol Cell Endocrinol,2017,456:95-101.[21]Poy MN,Hausser J,Trajkovski M,et al.miR-375 maintains normal pancreatic alpha- and beta-cell mass[J].Proc Natl Acad Sci U S A,2009,106(14):5813-5818.[22]Latreille M,Herrmanns K,Renwick N,et al.miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development[J].J Mol Med (Berl),2015,93(10):1159-1169.[23]Sun Y,Zhou Y,Shi Y,et al.Expression of miRNA-29 in Pancreatic beta Cells Promotes Inflammation and Diabetes via TRAF3[J].Cell Rep,2021,34(1):108576.[24]Roggli E,Gattesco S,Caille D,et al.Changes in microRNA expression contribute to pancreatic beta-cell dysfunction in prediabetic NOD mice[J].Diabetes,2012,61(7):1742-1751.[25]Bagge A,Dahmcke CM,Dalgaard LT.Syntaxin-1a is a direct target of miR-29a in insulin-producing beta-cells[J].Horm Metab Res,2013,45(6):463-466.[26]Plaisance V,Abderrahmani A,Perret-Menoud V,et al.MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells[J].J Biol Chem,2006,281(37):26932-26942.[27]Ramachandran D,Roy U,Garg S,et al.Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic beta-islets[J].FEBS J,2011,278(7):1167-1174.[28]Hu D,Wang Y,Zhang H,et al.Identification of miR-9 as a negative factor of insulin secretion from beta cells[J].J Physiol Biochem,2018,74(2):291-299.[29]Estrella IP,Garcia-Solis P,Solis-Sainz JC,et al.Expression of miRNA in obesity and insulin resistance: a review[J].Endokrynol Pol,2021,72(1):73-80.[30]Agbu P,Carthew RW.MicroRNA-mediated regulation of glucose and lipid metabolism[J].Nat Rev Mol Cell Biol,2021,22(6):425-438.[31]Luo A,Yan H,Liang J,et al.MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1[J].Gene,2017,627:194-201.[32]Yan C,Chen J,Li M,et al.A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice[J].Diabetologia,2016,59(7):1524-1532.[33]Kornfeld JW,Baitzel C,Konner AC,et al.Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b[J].Nature,2013,494(7435):111-115.[34]Agbu P,Carthew RW.MicroRNA-mediated regulation of glucose and lipid metabolism[J].Nat Rev Mol Cell Biol,2021,22(6):425-438.[35]Zheng H,Wan J,Shan Y,et al.MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase[J].Theranostics,2021,11(16):7829-7843.[36]Zheng LF,Chen PJ,Xiao WH.Roles and mechanism of microRNAs in the regulation of skeletal muscle insulin resistance[J].Acta Physiologica Sinica,2019,71(3):497-504.[37]Latouche C,Natoli A,Reddy-Luthmoodoo M,et al.MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes[J].PLoS One,2016,11(5):e155108.[38]Bork-Jensen J,Scheele C,Christophersen DV,et al.Glucose tolerance is associated with differential expression of microRNAs in skeletal muscle: results from studies of twins with and without type 2 diabetes[J].Diabetologia,2015,58(2):363-373.[39]Talari M,Kapadia B,Kain V,et al.MicroRNA-16 modulates macrophage polarization leading to improved insulin sensitivity in myoblasts[J].Biochimie,2015,119:16-26.[40]Arner P,Kulyte A.MicroRNA regulatory networks in human adipose tissue and obesity[J].Nat Rev Endocrinol,2015,11(5):276-288.[41]Kusminski CM,Bickel PE,Scherer PE.Targeting adipose tissue in the treatment of obesity-associated diabetes[J].Nat Rev Drug Discov,2016,15(9):639-660.[42]Brandao BB,Guerra BA,Mori MA.Shortcuts to a functional adipose tissue: The role of small non-coding RNAs[J].Redox Biol,2017,12:82-102.[43]Kazuki K,Satoru S,Hisakazu N,et al.Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice[J].PLoS One,2017,12(3):e0173661.[44]Zhang H,Guan M,Townsend KL,et al.MicroRNA-455 regulates brown adipogenesis via a novel HIF1an-AMPK-PGC1α signaling network[J].EMBO Reports,2015,16(10):1378-1393. [45]Lima VM,Liu J,Brand?觔o BB,et al.miRNA-22 deletion limits white adipose expansion and activates brown fat to attenuate high-fat diet-induced fat mass accumulation[J].Metabolism,2021,117:154723. [46]Thibonnier M,Esau C,Ghosh S,et al.Metabolic and energetic benefits of microRNA-22 inhibition[J].BMJ Open Diabetes Res Care,2020,8(1):e001478.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(09):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(09):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(09):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(09):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(09):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[7]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Journal of Medical Information,2018,31(09):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
[8]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(09):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[9]刘小红.长效胰岛素联合口服降糖药治疗2型糖尿病的
疗效与安全性评价[J].医学信息,2018,31(18):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
LIU Xiao-hong.Efficacy and Safety of Long Acting Insulin Combined with Oral Hypoglycemic Agents in Treatment of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(09):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
[10]鲍 哲,杨升伟,柯赛赛,等.益生元对2型糖尿病患者糖脂代谢的影响[J].医学信息,2018,31(18):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]
BAO Zhe,YANG Sheng-wei,KE Sai-sai,et al.Effect of Prebiotics on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes mellitus[J].Journal of Medical Information,2018,31(09):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]
[11]杨立顺,陈思佳,康建华.miRNA和脂联素在2型糖尿病发病机制中的研究[J].医学信息,2021,34(08):50.[doi:10.3969/j.issn.1006-1959.2021.08.013]
YANG Li-shun,CHEN Si-jia,KANG Jian-hua.Study on miRNA and Adiponectin in the Pathogenesis of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2021,34(09):50.[doi:10.3969/j.issn.1006-1959.2021.08.013]